Original ReportTopical High-Concentration (40%) Menthol—Somatosensory Profile of a Human Surrogate Pain Model
Key words
Cited by (0)
This study is a part of the Europain project, funded by the Innovative Medicines Initiative Joint Undertaking (IMI JU; www.imi.europa.eu) Grant no 115007 and was financially supported by BMBF (01EM0504) and an unrestricted financial grant from Pfizer Germany.
A.B. received honoraria for lectures from Grünenthal, Allergan, Astellas, Pfizer and payment for development of educational presentations from Pfizer. M.S. received honoraria for lectures from Grünenthal and Pfizer. R.B. has consultancies with and received honoraria from Pfizer, Genzyme, Grünenthal, Mundipharma, Allergan, Sanofi Pasteur, Medtronic, Eisai, UCB, Lilly, and Astellas; received grants from Pfizer, Grünenthal, Genzyme; and received payment for development of educational presentations from Pfizer, Medtronic. G.W. received honoraria for lectures from Grünenthal, Medtronic, Pfizer, and Mundipharma.
The authors declare that the sources of financial support had no influence on data assessment, analysis and interpretation and disclose potential conflicts of interest.